Multiple choice Response of non-small cell lung cancer to gefitinib is predicted by mutation in EGF receptor gene ABL oncogene Myc oncogene NF1 gene Reveal answer Fill a bubble to check yourself A Correct answer Explanation Approximately 10% of patients with non-small cell lung cancer respond to gefitinib, which is predicted by EGF receptor gene mutation.